Nalls Sherbakoff Group, LLC Neogenomics Inc Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 7 shares of NEO stock, worth $115. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7
Previous 14
50.0%
Holding current value
$115
Previous $173,000
34.1%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NEO
# of Institutions
295Shares Held
125MCall Options Held
698KPut Options Held
120K-
Black Rock Inc. New York, NY19.7MShares$324 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$232 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$114 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$109 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$108 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $2.07B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...